Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

A Derivative of Differentiation-Inducing Factor-3 Inhibits PAK1 Activity and Breast Cancer Cell Proliferation.

Oladimeji P, Kubohara Y, Kikuchi H, Oshima Y, Rusch C, Skerl R, Diakonova M.

Int J Cancer Clin Res. 2015;2(3):1-6.

2.

Differential gene regulation of GHSR signaling pathway in the arcuate nucleus and NPY neurons by fasting, diet-induced obesity, and 17β-estradiol.

Yasrebi A, Hsieh A, Mamounis KJ, Krumm EA, Yang JA, Magby J, Hu P, Roepke TA.

Mol Cell Endocrinol. 2016 Feb 15;422:42-56. doi: 10.1016/j.mce.2015.11.007. Epub 2015 Nov 11.

PMID:
26577678
3.

p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.

Siu MK, Kong DS, Ngai SY, Chan HY, Jiang L, Wong ES, Liu SS, Chan KK, Ngan HY, Cheung AN.

PLoS One. 2015 Jul 28;10(7):e0133467. doi: 10.1371/journal.pone.0133467. eCollection 2015.

4.

Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.

Hammer A, Diakonova M.

Adv Exp Med Biol. 2015;846:97-137. doi: 10.1007/978-3-319-12114-7_5. Review.

5.

Republished: tracing PAKs from GI inflammation to cancer.

Dammann K, Khare V, Gasche C.

Postgrad Med J. 2014 Nov;90(1069):657-68. doi: 10.1136/postgradmedj-2014-306768rep.

6.

The role of p21-activated kinases in hepatocellular carcinoma metastasis.

Tse EY, Ching YP.

J Mol Signal. 2014 Aug 1;9:7. doi: 10.1186/1750-2187-9-7. eCollection 2014. Review.

7.

P21 activated kinases: structure, regulation, and functions.

Rane CK, Minden A.

Small GTPases. 2014;5. pii: e28003. doi: 10.4161/sgtp.28003. Epub 2014 Mar 21. Review.

8.

PAK signaling in cancer.

Ye DZ, Field J.

Cell Logist. 2012 Apr 1;2(2):105-116.

9.

Androgen-induced cell migration: role of androgen receptor/filamin A association.

Castoria G, D'Amato L, Ciociola A, Giovannelli P, Giraldi T, Sepe L, Paolella G, Barone MV, Migliaccio A, Auricchio F.

PLoS One. 2011 Feb 16;6(2):e17218. doi: 10.1371/journal.pone.0017218.

10.

Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.

Rosenblatt AE, Garcia MI, Lyons L, Xie Y, Maiorino C, Désiré L, Slingerland J, Burnstein KL.

Endocr Relat Cancer. 2011 Feb 23;18(2):207-19. doi: 10.1677/ERC-10-0049. Print 2011 Apr.

11.

PAK1 as a therapeutic target.

Kichina JV, Goc A, Al-Husein B, Somanath PR, Kandel ES.

Expert Opin Ther Targets. 2010 Jul;14(7):703-25. doi: 10.1517/14728222.2010.492779. Review.

12.

Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer.

Yi C, Maksimoska J, Marmorstein R, Kissil JL.

Biochem Pharmacol. 2010 Sep 1;80(5):683-9. doi: 10.1016/j.bcp.2010.03.012. Epub 2010 Mar 17. Review.

13.

Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.

Morelli C, Lanzino M, Garofalo C, Maris P, Brunelli E, Casaburi I, Catalano S, Bruno R, Sisci D, Andò S.

Mol Cell Biol. 2010 Feb;30(3):857-70. doi: 10.1128/MCB.00824-09. Epub 2009 Nov 23.

14.

Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.

Guttilla IK, White BA.

J Biol Chem. 2009 Aug 28;284(35):23204-16. doi: 10.1074/jbc.M109.031427. Epub 2009 Jul 1.

15.

PAK signaling in oncogenesis.

Molli PR, Li DQ, Murray BW, Rayala SK, Kumar R.

Oncogene. 2009 Jul 16;28(28):2545-55. doi: 10.1038/onc.2009.119. Epub 2009 May 25. Review.

16.

p21-Activated kinase mediates rapid estradiol-negative feedback actions in the reproductive axis.

Zhao Z, Park C, McDevitt MA, Glidewell-Kenney C, Chambon P, Weiss J, Jameson JL, Levine JE.

Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7221-6. doi: 10.1073/pnas.0812597106. Epub 2009 Apr 9.

17.

Pak protein kinases and their role in cancer.

Dummler B, Ohshiro K, Kumar R, Field J.

Cancer Metastasis Rev. 2009 Jun;28(1-2):51-63. doi: 10.1007/s10555-008-9168-1. Review.

18.

Identification and analysis of evolutionary selection pressures acting at the molecular level in five forkhead subfamilies.

Fetterman CD, Rannala B, Walter MA.

BMC Evol Biol. 2008 Sep 24;8:261. doi: 10.1186/1471-2148-8-261.

19.

Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells.

Lombardi M, Castoria G, Migliaccio A, Barone MV, Di Stasio R, Ciociola A, Bottero D, Yamaguchi H, Appella E, Auricchio F.

J Cell Biol. 2008 Jul 28;182(2):327-40. doi: 10.1083/jcb.200712125. Epub 2008 Jul 21.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk